Fractional exhaled nitric oxide monitoring may provide a potential biomarker of disease activity and signify the emergency of pulmonary involvement in children with SLE.
Clinicians who treat osteoporotic fractures should prescribe anti-osteoporotic drugs to prevent secondary vertebral and non-vertebral fractures.
Underlying synovitis and enthesitis may go undetected in clinical findings, but can be detected by power Doppler ultrasounds.
Researchers from the Feinstein Institute for Medical Research may have identified a potential cause for lupus, which may lead to new treatment options.
The risk for death associated with SLE remains high for patients with SLE-associated PAH and researchers have identified the biomarkers that may lead to early detection.
Patients with RA have a significantly higher risk of cardiovascular disease, and cardiac magnetic resonance can help with early diagnosis.
A sizeable percentage of patients with rheumatoid arthritis who are in clinical remission have evidence of disease activity on magnetic resonance imaging of the foot that is mostly affected.
Eating fish at least twice a week may significantly reduce the pain and swelling associated with rheumatoid arthritis.
In patients with tophaceous gout, combination therapy of lesinurad plus febuxostat is more effective at reducing serum urate levels than febuxostat monotherapy.
Cumulative steroid dosage is a risk factor for the development of osteonecrosis, which is the most frequent type of damage in lupus patients.
Longitudinal opioid prescribing patterns suggest that regular use among patients with rheumatoid arthritis (RA) is slightly declining.
Adjunctive subcutaneous belimumab plus standard care improves SLE Responder Index response and decreases disease flares
The Montreal Cognitive Assessment is superior to the Mini-Mental State Examination at detecting cognitive dysfunction in SLE.
Lesinurad combined with febuxostat showed superior serum urate reduction vs febuxostat alone in patients with tophaceous gout requiring additional therapy.
Use of the JAK inhibitor peficitinib in combination with certain csDMARDs results in a dose-dependent ACR20 response rate in patients with RA over 12 weeks.
MRI may assist in identifying patients with unclassified arthritis who will develop rheumatoid arthritis (RA) — primarily in patients with UA presenting with oligoarthritis.
Patients with multiple sclerosis (MS) have lower bone mineral density and greater rates of osteoporosis than healthy controls.
Approximately 1 in 3 patients with RA who discontinued tofacitinib maintained low disease activity after 1 year.
Muscle MRI may complement a physician's objective assessment in juvenile dermatomyositis, although negative MRI findings should not preclude treatment continuation.
The Dietary Approaches to Stop Hypertension (DASH) diet is effective for prevention of gout.
High serum uric acid levels are associated with a high risk of new-onset gout and gout recurrence, while lowering SUA levels can significantly reduce incident and recurrent gout.
Much concern has been voiced regarding legislation allowing the substitution of biosimilars for branded drugs.
Preclinical alterations in levels of soluble mediators may predict transition to SLE for unaffected relatives of patients with SLE.
This study included phase 3 trial in patients taking baricitinib, adalimumab, or placebo in addition to methotrexate background therapy.
A phase 3, double-blind, randomized placebo-controlled study was conducted in 551 patients with active RA who received secukinumab, abatacept, or placebo.
Consuming adequate amounts of the right nutrients can help relieve symptoms and improve outcomes in patients with systemic lupus erythematosus.
Telerheumatology can improve healthcare access, patient outcomes, and costs
The innovative triage and referral system introduced by CReATe Rheum successfully facilitated timely access to care for rheumatology patients. Further long-term follow-up demonstrated that, despite an increasing number of referrals, CReATe Rheum can accurately cope with increased demand.
"As [a member] of the NIH Task Force on pain, I would say that one of the things that's important to show is that an interdisciplinary model and a multimodal approach are effective and cost-effective, as they certainly are expensive."
Dermatologists are in a key position to screen for psoriatic arthritis (PsA), as the overlapping and variable symptoms of the disease require multidisciplinary care.
Clinical Pain Advisor Articles
- FDA's Flush List: Assessing the Environmental Impact
- Intrathecal Ziconotide Long-Term Efficacy and Safety for Severe Chronic Pain
- Sciatic Plus Femoral Nerve Blocks Effective on Total Hip Arthroplasty-Related Pain
- Yoga Improves Health Outcomes in Veterans With Chronic Low Back Pain
- Morphine Lacks Efficacy for RA, Chronic Fatigue Syndrome and Fibromyalgia
- Uniport vs Multiport Catheters for Labor Epidural Analgesia
- Disease Activity Biomarker in Pediatric SLE
- Guidance on Preventing Medical Billing Errors
- Preemptive Analgesia With Acetaminophen Reduces Headaches Associated With Electroconvulsive Therapy
- Minimum Headache Duration Requiring Subarachnoid Hemorrhage Evaluation